Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration
- PMID: 38630166
- DOI: 10.1007/s11136-024-03649-5
Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration
Abstract
Background: The second version of the Short-Form 6-Dimension (SF-6Dv2) classification system has recently been developed. The objective of this study was to develop a value set for SF-6Dv2 based on the societal preferences of a general population in the capital of Iran.
Methods: A representative sample of the capital of Iran (n = 3061) was recruited using a stratified multistage quota sampling technique. Face-to-face interviews were conducted using binary choice sets from the international valuation protocol of the discrete choice experiment with duration. The conditional logit was used to estimate the final value set, and a latent class model was employed to assess heterogeneity of preferences.
Results: Coefficients generated from the models were logically consistent and significant. The best model was the one that included an additional interaction term for cases where one or more dimensions reached their most severe levels. It provides a value set with logical consistent coefficients and the lowest percentage of worse than death health states. Predicted values for the SF-6Dv2 were within the range of - 0.796-1. Pain dimension had the largest impact on utility decrement, whereas vitality had the least impact. The presence of preference heterogeneity was evident, and the Bayesian Information Criterion indicated the optimal fit for a latent class model with two classes.
Conclusion: This study provided the SF-6Dv2 value set for application in the context of Iran. This value set will facilitate the use of the SF-6Dv2 instrument in health economic evaluations and clinical settings.
Keywords: Discrete choice experiment; International valuation protocol; SF-6Dv2; Value set.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
The Short Form 6 Dimensions (SF-6D): Development and Evolution.Appl Health Econ Health Policy. 2025 Jan;23(1):19-33. doi: 10.1007/s40258-024-00919-8. Epub 2024 Oct 26. Appl Health Econ Health Policy. 2025. PMID: 39460886 Free PMC article. Review.
-
Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, Canada.Int J Health Policy Manag. 2024;13:8404. doi: 10.34172/ijhpm.8404. Epub 2024 Sep 7. Int J Health Policy Manag. 2024. PMID: 39620535 Free PMC article.
-
Comparison of four approaches in eliciting health state utilities with SF-6Dv2.Eur J Health Econ. 2025 Jun;26(4):589-604. doi: 10.1007/s10198-024-01723-w. Epub 2024 Sep 28. Eur J Health Econ. 2025. PMID: 39340750
-
Valuing the SF-6Dv2 Classification System in the United Kingdom Using a Discrete-choice Experiment With Duration.Med Care. 2020 Jun;58(6):566-573. doi: 10.1097/MLR.0000000000001324. Med Care. 2020. PMID: 32221100
-
Valuation survey for SF-6Dv2 in Japan based on the international protocol.Qual Life Res. 2025 Feb;34(2):445-455. doi: 10.1007/s11136-024-03830-w. Epub 2024 Nov 27. Qual Life Res. 2025. PMID: 39602017 Free PMC article.
Cited by
-
Health utility scores of six common cancers in China measured by SF-6Dv2.Health Qual Life Outcomes. 2025 Jan 12;23(1):5. doi: 10.1186/s12955-025-02332-8. Health Qual Life Outcomes. 2025. PMID: 39799326 Free PMC article.
-
The Short Form 6 Dimensions (SF-6D): Development and Evolution.Appl Health Econ Health Policy. 2025 Jan;23(1):19-33. doi: 10.1007/s40258-024-00919-8. Epub 2024 Oct 26. Appl Health Econ Health Policy. 2025. PMID: 39460886 Free PMC article. Review.
-
Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, Canada.Int J Health Policy Manag. 2024;13:8404. doi: 10.34172/ijhpm.8404. Epub 2024 Sep 7. Int J Health Policy Manag. 2024. PMID: 39620535 Free PMC article.
-
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities.Appl Health Econ Health Policy. 2025 Mar;23(2):319-327. doi: 10.1007/s40258-024-00929-6. Epub 2024 Dec 6. Appl Health Econ Health Policy. 2025. PMID: 39643791
-
Comparison of four approaches in eliciting health state utilities with SF-6Dv2.Eur J Health Econ. 2025 Jun;26(4):589-604. doi: 10.1007/s10198-024-01723-w. Epub 2024 Sep 28. Eur J Health Econ. 2025. PMID: 39340750
References
-
- Bank, W. (2023). https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=IR .
-
- Kennedy-Martin, M., Slaap, B., Herdman, M., van Reenen, M., Kennedy-Martin, T., Greiner, W., Busschbach, J., & Boye, K. S. (2020). Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. The European Journal of Health Economics, 21, 1245–1257. - DOI - PubMed - PMC
-
- Devlin, N., Parkin, D., & Janssen, B. (2020). Methods for analysing and reporting EQ-5D data. Springer Nature. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources